Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting The Prognosis Of Covid-19 Patients With Circulating Inflammatory and Coagulation Markers

NCT04997928 is registered in ClinicalTrials.gov with Saglik Bilimleri Universitesi as lead sponsor.

NCT NCT04997928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04997928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting The Prognosis Of Covid-19 Patients With Circulating Inflammatory and Coagulation Markers
Lead sponsor
Saglik Bilimleri Universitesi
Phase
Observational
Overall status
Unknown status
Start date
January 18, 2021
Completion date
September 30, 2021
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 positivity confirmed with pcr positivity in the nasopharyngeal swab, healthy control patients of the same age, patients among 20 to 90 years of age, patients who did not vaccinate against covid-19, symptomatic covid -19 positive patients who require hospitalization